Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUNDS AS PROTEIN KINASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/078401
Kind Code:
A1
Abstract:
Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Inventors:
TAN HAOHAN (CN)
LI ZHIFU (CN)
LIU BIN (CN)
WANG YUNLING (CN)
HE CHENGXI (CN)
LIU QIHONG (CN)
XU HUA (CN)
QI YANGLI (CN)
LIU YANXIN (CN)
LIN SHU (US)
ZHAO XINGDONG (CN)
WANG WEIBO (US)
Application Number:
PCT/CN2022/129918
Publication Date:
May 11, 2023
Filing Date:
November 04, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FOCHON BIOSCIENCES LTD (CN)
International Classes:
C07D471/04; A61K31/4353; A61P35/00; C07D487/04
Domestic Patent References:
WO2013130660A12013-09-06
WO2022140456A12022-06-30
WO2022143629A12022-07-07
Foreign References:
CN111205281A2020-05-29
CN107207441A2017-09-26
Other References:
LIPING H. PETTUS, KRISTIN L. ANDREWS, SHON K. BOOKER, JIE CHEN, VICTOR J. CEE, FRANK CHAVEZ, YUPING CHEN, HEATHER EASTWOOD, NADIA : "Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 59, no. 13, 14 July 2016 (2016-07-14), US , pages 6407 - 6430, XP055761979, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.6b00610
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: